Tilray (TLRY) Stock News
$TLRY · NASDAQ · HEALTHCARE · 2 stories in 30 daysBORSA has published 2 stories on Tilray (TLRY) in the past 30 days. BORSA’s news read on TLRY is bullish at 60/100, +5 over 24 hours, based on 1 company event over the past 7 days. Tilray last reported quarterly results on Jul 28, 2026, for the quarter ended May 31, 2026.
The wire on $TLRY
newest first · updated · direct subject stories onlyTilray Medical Wins INFARMED Approval for In-House EU-GMP Testing in Portugal
Portugal's INFARMED authorized Tilray Medical's Cantanhede facility to conduct microbiological and chemical/physical testing on-site. The move cuts third-party dependency, lowers batch-release costs, and speeds product to market in regulated European medical cannabis markets.
bullish 65 · impact 35